Clinical Trial Update: Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Clinical trial update on the Phase 2 study of IB-FOLFIRI for metastatic colorectal cancer with BRAF V600E mutation, currently recruiting to evaluate safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• IB-FOLFIRI

Snippet

Sponsor: Sun Yat-sen University | Conditions: BRAF V600 Colorectal Cancer | Phase 2 | Status: RECRUITING